ZOCGER REPORT AT THREE DEPARTMENTS OF THE CAN THO CENTRAL GENERAL HOSPITAL

On November 11–12, 2025, Medbolide Pharmaceutical JSC held an informational session to introduce ZOCGER (Capsaicin 0.075%) to the Departments of Orthopedics and Rheumatology, Outpatient Services, and Neurology at Can Tho Central General Hospital.
The presentations were attended by many doctors and healthcare professionals.
Medbolide presented clinical recommendations and studies demonstrating the benefits of ZOCGER (Capsaicin 0.075%) in pain management through a novel mechanism, along with the drug’s efficacy and safety profile.

Following the presentations, the doctors engaged in extensive discussions and expressed interest in the mechanism of action of ZOCGER (Capsaicin 0.075%) for pain management in conditions such as diabetic neuropathy, postherpetic neuralgia, and musculoskeletal pain.
At the conclusion of the presentation, Medbolide Pharmaceutical JSC expressed its gratitude and hope to continue partnering with Can Tho Central General Hospital in providing solutions to improve patients’ quality of life.